- Do you own shares of Onyx Pharmaceuticals, Inc. (NASDAQ GS: ONXX )?
- Did you purchase any of your shares prior to August 25, 2013?
- Do you think the proposed buyout price is too low?
- Do you want to discuss your rights?
Biotech columnist Adam Feuerstein answers readers' questions about health care.
Biotech M&A deals that haven't happened because of price argue against the risk of a bubble.
Trade-Ideas LLC identified Onyx Pharmaceuticals (ONXX) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate